Form 4: Director Paul Stuka Buys InspireMD Shares

InspireMD Director Paul Stuka acquired 5,073 shares of common stock at $1.86 per share, increasing his direct beneficial ownership.

Summary

• Paul Stuka, a Director of InspireMD, Inc. (NSPR), purchased 5,073 shares of common stock.
• The transaction occurred on December 5, 2025, at a price of $1.86 per share.
• Following this transaction, Stuka directly beneficially owns 388,918 shares of common stock.
• Stuka is also deemed to indirectly beneficially own 444,195 shares through Osiris Investment Partners, L.P., where he serves as the managing member of the general partner. He disclaims beneficial ownership of these indirect shares except to the extent of his pecuniary interest, and no transaction was effected by him with respect to these securities.

Sentiment

Score: 7

Explanation: A director's purchase of company stock is generally seen as a positive signal, indicating confidence in the company's future performance.

Positives

• A director, Paul Stuka, purchased 5,073 shares of common stock, indicating confidence in the company's future prospects.
• The purchase price of $1.86 per share provides a specific valuation point for the insider's investment.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Paul Stuka, a Director, is the managing member of Osiris Partners, LLC, which is the general partner of Osiris Investment Partners, L.P.
• Osiris Investment Partners, L.P. indirectly holds 444,195 shares of InspireMD, Inc. common stock, which Paul Stuka may be deemed to beneficially own to the extent of his pecuniary interest.
• The filing clarifies that no transaction was effected by the Reporting Person with respect to these indirectly held securities, and they are included for informational purposes only.

Stakeholder Impact

• Shareholders: May view the insider purchase as a positive signal, potentially increasing confidence in the stock and its future prospects.

Key Dates

Recommendation

The purchase of shares by a director, Paul Stuka, signals insider confidence in InspireMD, Inc.'s prospects. While a positive indicator, this single transaction alone does not provide sufficient information to warrant a 'strong buy' or 'sell' recommendation without a deeper analysis of the company's financials, strategic direction, and market conditions. It reinforces a 'hold' position for existing investors and suggests potential for further due diligence for prospective investors.

Keywords

InspireMD, NSPR, Paul Stuka, Insider Trading, Form 4, Stock Purchase, Director, Beneficial Ownership